Methicillin-Resistant Staphylococcus Aureus (MRSA)

Project Overview

MRSA is spreading to the extent that it is becoming a major public health and public safety concern in the United States. ?MRSA is associated with increased hospital length of stays, higher costs, and mortality rates of 6.3 deaths per 100,000 infected patients.

Estimates based on calendar year 2005 US data:

94,000+ invasive MRSA infections in population
19,000 (approx) died (18%) during initial population
86% of invasive MRSA disease ? exposures to hospitals or health care settings
14% - no recent hospitalization or other risk factors
Majority of cases overall had infection manifest or discovered when the person was out of the hospital:
- 58% were community-onset HA-MRSA infections (e.g., persons recently discharged from a hospital or recently had surgery)
- 27% were hospital-onset HA-MRSA infections (i.e., the typical nosocomial MRSA infections)
- 14% were community associated CA-MRSA infections

Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;1763-1771.

Main Objective

To reduce MRSA infections and transmission.

Measures

Infection rate
Transmission Rate

Links

Questions?

For more information, contact Michelle Mills, Project Director, at 303.847.1727 or mmills@coqio.sdps.org or Shari Ward, Project Manager, at 303.669.9581 or sward@coqio.sdps.org or Judy Fye at 720.206.9342 or jfye@coqio.sdps.org.

The Colorado Foundation for Medical Care (CFMC), the Medicare quality improvement organization for Colorado, prepared this material under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS Policy.